Advertisement
Original research| Volume 9, ISSUE 1, P9-14, February 2015

Download started.

Ok

Health care delivery in type 2 diabetes. A survey in an Italian primary care practice

      Highlights

      • The paper analyzes the quality of diabetic care provided by an Italian primary care practice.
      • HbA1c was >8% in 22% of patients and that figure did not change during the follow-up.
      • SBP and LDL-C was at target in a minority of patients.
      • Only a third of patients was prescribed statins.
      • Efforts are needed to improve the management of type 2 diabetes in primary care.

      Abstract

      Aims

      Evidence-based guidelines provide targets and performance measures for the treatment of type 2 diabetic patients but a wide gap separates guidelines-driven recommendations from their clinical application, a phenomenon hindering the transfer of proven benefits to affected populations.

      Methods

      We analyzed the quality of diabetic care delivered by 8 general practitioners joint in a group practice attending 571 diabetic patients (5.6% of the total enlisted subjects) by assessing process (% of HbA1c, SBP and LDL-C determinations) and intermediate outcome (% of patients with HbA1c <7% vs >8%, systolic BP <130 mmHg vs >140 mmHg, LDL-cholesterol <100 mg/dL vs >130 mg/dL) indicators.

      Results

      HbA1c was at target in 49% of patients and >8% in 22%; SBP and LDL-C determination was available in about two-thirds of patients, only a minority at target for SBP and LDL-C. Antihyperglycemic and antihypertensive treatment was prescribed in most patients but only a third was on statins. During the post-evaluation phase, percentages of patients with HbA1c >8%, SBP < 130 mmHg and LDL-C < 100 mg/dL and the drug prescription pattern did not change.

      Conclusions

      Several weaknesses affect primary care delivery to type 2 diabetic patients and efforts are needed to improve the management of this high-risk group.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kannel W.B.
        • McGee D.L.
        Diabetes and cardiovascular disease: the Framingham study.
        JAMA. 1979; 241: 2035-2038
        • Fuller J.H.
        • Shipley M.J.
        • Rose G.
        • Jarrett R.J.
        • Keen H.
        Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.
        BMJ. 1983; 287: 867-870
        • Gaede P.
        • Vedel P.
        • Larsen N.
        • Jensen G.V.
        • Parving H.H.
        • Pedersen O.
        Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
        N. Engl. J. Med. 2003; 348: 383-393
      1. Standards of medical care in diabetes—2013.
        Diabetes Care. 2013; 36: S11-S66
        • Saydah S.H.
        • Fradkin J.
        • Cowie C.C.
        Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.
        JAMA. 2004; 291: 335-342
        • Harris S.B.
        • Ekoé J.M.
        • Zdanowicz Y.
        • Webster-Bogaert S.
        Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study).
        Diabetes Res. Clin. Pract. 2005; 70: 90-97
        • de Pablos-Velasco P.
        • Parhofer K.G.
        • Bradley C.
        • Eschwège E.
        • Gönder-Frederick L.
        • Maheux P.
        • Wood I.
        • Simon D.
        Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study.
        Clin. Endocrinol. (Oxf.). 2014; 80: 47-56
        • Rossi M.C.
        • Nicolucci A.
        • Arcangeli A.
        • Cimino A.
        • De Bigontina G.
        • Giorda C.
        • Meloncelli I.
        • Pellegrini F.
        • Valentini U.
        • Vespasiani G.
        • Associazione Medici Diabetologi Annals Study Group
        Baseline quality-of-care data from a quality-improvement program implemented by a network of diabetes outpatient clinics.
        Diabetes Care. 2008; 31: 2166-2168
        • Vaccaro O.
        • Boemi M.
        • Cavalot F.
        • De Feo P.
        • Miccoli R.
        • Patti L.
        • Rivellese A.A.
        • Trovati M.
        • Ardigò D.
        • Zavaroni I.
        • MIND-IT Study Group
        The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy.
        Atherosclerosis. 2008; 198: 396-402
        • Rossi M.C.
        • Lucisano G.
        • Comaschi M.
        • Coscelli C.
        • Cucinotta D.
        • Di Blasi P.
        • Bader G.
        • Pellegrini F.
        • Valentini U.
        • Vespasiani G.
        • Nicolucci A.
        • AMD-QUASAR Study Group
        Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study.
        Diabetes Care. 2011; 34: 347-352
        • Bruno G.
        • Bonora E.
        • Miccoli R.
        • Vaccaro O.
        • Rossi E.
        • Bernardi D.
        • De Rosa M.
        • Marchesini G.
        • SID-CINECA ARNO Working Group
        Quality of diabetes care in Italy: information from a large population-based multiregional observatory (ARNO diabetes).
        Diabetes Care. 2012; 35: e64
        • Perria C.
        • Mandolini D.
        • Guerrera C.
        • Jefferson T.
        • Billi P.
        • Calzini V.
        • Fiorillo A.
        • Grasso G.
        • Leotta S.
        • Marrocco W.
        • Suraci C.
        • Pasquarella A.
        Implementing a guideline for the treatment of type 2 diabetics: results of a cluster-randomized controlled trial (C-RCT).
        BMC Health Serv. Res. 2007; 7: 79
        • Mazzaglia G.
        • Yurgin N.
        • Boye K.S.
        • Trifirò G.
        • Cottrell S.
        • Allen E.
        • Filippi A.
        • Medea G.
        • Cricelli C.
        Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data.
        Pharmacol. Res. 2008; 57: 358-363
        • Ravera M.
        • Noberasco G.
        • Re M.
        • Filippi A.
        • Gallina A.M.
        • Weiss U.
        • Cannavò R.
        • Ravera G.
        • Cricelli C.
        • Deferrari G.
        Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
        Nephrol. Dial. Transplant. 2009; 24: 1528-1533
        • Tonkin A.M.
        • Chen L.
        Where on the healthcare continuum should we invest? The case for primary care?.
        Heart Lung Circ. 2009; 18: 108-113
        • Doran T.
        • Fullwood C.
        • Gravelle H.
        • Reeves D.
        • Kontopantelis E.
        • Hiroeh U.
        • Roland M.
        Pay-for-performance programs in family practices in the United Kingdom.
        N. Engl. J. Med. 2006; 355: 375-384
      2. (accessed 27.01.14)
        • Fattore G.
        • Salvatore D.
        Network organizations of general practitioners: antecedents of formation and consequences of participation.
        BMC Health Serv. Res. 2010; 10: 118
      3. Standard Italiani per la Cura del Diabete Mellito Tipo 2. Edizione per la medicina generale. @ http://www.simg.it/documenti/collaborazioni/amd/AMD_SID_SIMMG_2011%20definitivo.pdf.

        • Phillips L.S.
        • Branch W.T.
        • Cook C.B.
        • Doyle J.P.
        • El-Kebbi I.M.
        • Gallina D.L.
        • Miller C.D.
        • Ziemer D.C.
        • Barnes C.S.
        Clinical inertia.
        Ann. Intern. Med. 2001; 135: 825-834
        • De Berardis G.
        • Pellegrini F.
        • Franciosi M.
        • Belfiglio M.
        • Di Nardo B.
        • Greenfield S.
        • Kaplan S.H.
        • Rossi M.C.
        • Sacco M.
        • Tognoni G.
        • Valentini M.
        • Nicolucci A.
        • QuED Study
        Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics.
        Diabetes Care. 2004; 27: 398-406
        • Di Bonito P.
        • De Natale C.
        • Salvatore T.
        • Vaccaro O.
        • Armentano V.
        • Adinolfi D.
        • Giugliano R.
        • Capaldo B.
        • DIABAGE Study Group.
        Management of type 2 diabetic patients attending diabetic outpatient clinics compared with those cared for by the general practitioners: an experience of integrated diabetes management.
        Ann. Ist. Super. Sanita. 2009; 45: 162-167
        • Noale M.
        • Limongi F.
        • Scafato E.
        • Maggi S.
        • Crepaldi G.
        Longevity and health expectancy in an ageing society: implications for public health in Italy.
        Ann. Ist. Super. Sanita. 2012; 48: 292-299
        • Gerstein H.C.
        • Miller M.E.
        • Genuth S.
        • Ismail-Beigi F.
        • Buse J.B.
        • Goff Jr., D.C.
        • Probstfield J.L.
        • Cushman W.C.
        • Ginsberg H.N.
        • Bigger J.T.
        • Grimm Jr., R.H.
        • Byington R.P.
        • Rosenberg Y.D.
        • Friedewald W.T.
        • ACCORD Study Group
        Long-term effects of intensive glucose lowering on cardiovascular outcomes.
        N. Engl. J. Med. 2011; 364: 818-828
        • Boussageon R.
        • Bejan-Angoulvant T.
        • Saadatian-Elahi M.
        • Lafont S.
        • Bergeonneau C.
        • Kassaï B.
        • Erpeldinger S.
        • Wright J.M.
        • Gueyffier F.
        • Cornu C.
        Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
        BMJ. 2011; 343: d4169
        • Garfinkel D.
        • Mangin D.
        Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy.
        Arch. Intern. Med. 2010; 170: 1648-1654
        • Inzucchi S.E.
        • Bergenstal R.M.
        • Buse J.B.
        • Diamant M.
        • Ferrannini E.
        • Nauck M.
        • Peters A.L.
        • Tsapas A.
        • Wender R.
        • Matthews D.R.
        Management of hyperglycaemia in type 2 diabetes: a patient-centered approach Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
        Diabetologia. 2012; 55: 1577-1596
        • Visca M.
        • Donatini A.
        • Gini R.
        • Federico B.
        • Damiani G.
        • Francesconi P.
        • Grilli L.
        • Rampichini C.
        • Lapini G.
        • Zocchetti C.
        • Di Stanislao F.
        • Brambilla A.
        • Moirano F.
        • Bellentani D.
        Group versus single handed primary care: a performance evaluation of the care delivered to chronic patients by Italian GPs.
        Health Policy. 2013; 113: 188-198
        • Fantini M.P.
        • Compagni A.
        • Rucci P.
        • Mimmi S.
        • Longo F.
        General practitioners’ adherence to evidence-based guidelines: a multilevel analysis.
        Health Care Manage. Rev. 2012; 37: 67-76
        • Gnavi R.
        • Picariello R.
        • la Karaghiosoff L.
        • Costa G.
        • Giorda C.
        Determinants of quality in diabetes care process: the population-based Torino Study.
        Diabetes Care. 2009; 32: 1986-1992
        • Franzini L.
        • Ardigò D.
        • Cavalot F.
        • Miccoli R.
        • Rivellese A.A.
        • Trovati M.
        • Zavaroni I.
        • Vaccaro O.
        • IT Study Group of the Italian Society of Diabetology
        Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.
        Nutr. Metab. Cardiovasc. Dis. 2013; 23: 235-241
        • Vaccaro O.
        • Franzini L.
        • Miccoli R.
        • Cavalot F.
        • Ardigò D.
        • Boemi M.
        • De Feo P.
        • Reboldi G.
        • Rivellese A.A.
        • Trovati M.
        • Zavaroni I.
        • MIND.IT Study Group
        Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial.
        Diabetes Care. 2013; 36: 2566-2572
        • Cushman W.C.
        • Evans G.W.
        • Byington R.P.
        • Goff Jr., D.C.
        • Grimm Jr., R.H.
        • Cutler J.A.
        • Simons-Morton D.G.
        • Basile J.N.
        • Corson M.A.
        • Probstfield J.L.
        • Katz L.
        • Peterson K.A.
        • Friedewald W.T.
        • Buse J.B.
        • Bigger J.T.
        • Gerstein H.C.
        • Ismail-Beigi F.
        • ACCORD Study Group
        Effects of intensive blood-pressure control in type 2 diabetes mellitus.
        N. Engl. J. Med. 2010; 362: 1575-1585
        • Mancia G.
        • Fagard R.
        • Narkiewicz K.
        • Redón J.
        • Zanchetti A.
        • Böhm M.
        • Christiaens T.
        • Cifkova R.
        • De Backer G.
        • Dominiczak A.
        • Galderisi M.
        • Grobbee D.E.
        • Jaarsma T.
        • Kirchhof P.
        • Kjeldsen S.E.
        • Laurent S.
        • Manolis A.J.
        • Nilsson P.M.
        • Ruilope L.M.
        • Schmieder R.E.
        • Sirnes P.A.
        • Sleight P.
        • Viigimaa M.
        • Waeber B.
        • Zannad F.
        List of authors Task Force Members: 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
        J. Hypertens. 2013; 31: 1281-1357
        • Collins R.
        • Armitage J.
        • Parish S.
        • Sleigh P.
        • Peto R.
        • Heart Protection Study Collaborative Group
        MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
        Lancet. 2003; 361: 2005-2016
        • Colhoun H.M.
        • Betteridge D.J.
        • Durrington P.N.
        • Hitman G.A.
        • Neil H.A.
        • Livingstone S.J.
        • Thomason M.J.
        • Mackness M.I.
        • Charlton-Menys V.
        • Fuller J.H.
        • CARDS Investigators
        Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
        Lancet. 2004; 364: 685-696
        • Stone N.J.
        • Robinson J.
        • Lichtenstein A.H.
        • Merz C.N.
        • Blum C.B.
        • Eckel R.H.
        • Goldberg A.C.
        • Gordon D.
        • Levy D.
        • Lloyd-Jones D.M.
        • McBride P.
        • Schwartz J.S.
        • Shero S.T.
        • Smith Jr., S.C.
        • Watson K.
        • Wilson P.W.
        2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2013; 12 (Epub ahead of print)
        • Avogaro A.
        • Guida P.
        • Giorda C.
        • Mannucci E.
        • Medea G.
        • Comaschi M.
        • Velussi M.
        • Armienti G.
        • Zucchetti R.
        • Progetto DARIO (DIAbetic Register in Italian Oggices)
        The underuse of statin in type 2 diabetic patients attending diabetic clinics in Italy.
        Nutr. Metab. Cardiovasc. Dis. 2007; 17: 32-40
        • Giorda C.B.
        • Avogaro A.
        • Maggini M.
        • Lombardo F.
        • Mannucci E.
        • Turco S.
        • Alegiani S.S.
        • Raschetti R.
        • Velussi M.
        • Ferrannini E.
        • Diabetes and Informatics Study Group
        Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.
        Diabetes Care. 2008; 31: 2154-2159
        • Lo Scalzo A.
        • Donatini A.
        • Orzella L.
        • Cicchetti A.
        • Profili S.
        • Maresso A.
        Italy: health system review.
        Health Syst. Transition. 2009; 11: 1-216
        • Kerr E.A.
        • Krein S.L.
        • Vijan S.
        • Hofer T.P.
        • Hayward R.A.
        Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures.
        Am. J. Manage. Care. 2001; 7: 1033-1043